By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > AstraZeneca Stock: Mispriced Growth Following The Oncology Segment Success (NASDAQ:AZN)
News

AstraZeneca Stock: Mispriced Growth Following The Oncology Segment Success (NASDAQ:AZN)

News
Last updated: 2025/12/19 at 7:37 AM
By News
Share
3 Min Read
SHARE

This article was written by

Hi, I’m Alex! I focus on European financials and high-tech industries (mainly fintech, pharma, and medtech). My background goes from investor relations for tech startups, through mutual fund strategy divisions in Germany, to quantitative risk and derivatives analytics. I hold a Master in Management (Data & Business Analytics) from the Frankfurt School of Finance & Management and I’m currently working toward the CFA and FRM. My personal investing approach: I invest mainly long, with derivative overlays for hedging and risk control. My goal is to mix quantitative models with fundamental research, with the goal to understand the drivers behind companies and test whether their growth stories hold up in numbers. What I Write About: • Sectors: Financials, fintech, pharma, medtech • Focus: Small industry studies and equity research • Method: Select an industry, build a set of comparable firms, talk to people in the field (non-insider), map the main drivers, and weigh growth potential against valuation • Output: My view on whether a company fits into a solid long-term portfolio My goal is learning: I write on Seeking Alpha to share my learning process – connecting data, markets, and practitioner insights. I’m not trying to predict markets, but to understand them better and help others do the same.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Short position through short-selling of the stock, or purchase of put options or similar derivatives in AZN over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

News December 19, 2025 December 19, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Goldman Sachs Large Cap Growth Insights Fund Q3 2025 Commentary (GLCGX)

By News
News

Howard Hughes Holdings Stock Continues Its Transformation (NYSE:HHH)

By News
News

NewLake Capital Partners Stock Is Upgraded To Buy On Regulatory Shift (OTCMKTS:NLCP)

By News
News

Silver, Not Silicon: Why The Next Market Leader In 2026 Won’t Be AI (NYSEARCA:SLV)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?